Extrapolation and dosing recommendations for raxibacumab in children from birth to age <18 years.

Published in: British journal of clinical pharmacology (2021)

Age-related maturation processes may affect raxibacumab clearance in very young patients. The proposed dosing regimens take into account effects of body weight and maturation processes on the elimination of raxibacumab.

Keyphrases

body weight
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
middle aged
patient reported